New Product: Tekamlo™, a Combination of Aliskiren and Amlodipine
Tekamlo™, a Combination of Aliskiren and Amlodipine
Novartis Receives FDA Approval of Tekamlo™, a Combination of Aliskiren and Amlodipine to Treat High Blood Pressure: Tekamlo is approved as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals and as replacement therapy for patients whose blood pressure is not adequately controlled with either aliskiren or amlodipine alone. Novartis Press Release
DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.
Copyright @ 1999-2012 Diabetes In Control, Inc.. All rights reserved.
Novartis Receives FDA Approval of Tekamlo™, a Combination of Aliskiren and Amlodipine to Treat High Blood Pressure: Tekamlo is approved as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals and as replacement therapy for patients whose blood pressure is not adequately controlled with either aliskiren or amlodipine alone. 
Entries (RSS News)
